Skip to main content
OpenTrials

Clinical trial condition

Small-cell Lung Cancer

Explore clinical trials studying Small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

75 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Small-cell Lung Cancer trial results

Active, Not Recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

NCT06211036

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Infirmary Cancer Center Mobile, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
View all 219 locations
View Trial Details
Active, Not Recruiting

TH1902 in Patients With Advanced Solid Tumors

NCT04706962

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Pennsylvania Cancer Specialists Research Institute Gettysburg, Pennsylvania, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions